Literature DB >> 15028296

alpha-Synuclein A53T substitution associated with Parkinson disease also marks the divergence of Old World and New World primates.

Bruce A Hamilton1.   

Abstract

The alpha-synuclein mutation Ala53Thr is associated with increased oligomerization, toxicity, and early onset Parkinson disease in humans, but 53Thr is the normal residue in other species. Comparative sequencing of SNCA genes shows that 53Ala marks the divergence of Old World and New World primates, in an otherwise constrained protein region. These results have implications for interpreting Parkinson disease models and suggest that other long-lived mammals have different mechanisms to forestall alpha-synucleinopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028296     DOI: 10.1016/j.ygeno.2003.09.016

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  17 in total

1.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

2.  The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse α-synuclein.

Authors:  Lijuan Kang; Kuen-Phon Wu; Michele Vendruscolo; Jean Baum
Journal:  J Am Chem Soc       Date:  2011-08-08       Impact factor: 15.419

Review 3.  Evolution of neurodegeneration.

Authors:  Mark R Cookson
Journal:  Curr Biol       Date:  2012-09-11       Impact factor: 10.834

4.  The benefits and limitations of animal models for translational research in neurodegenerative diseases.

Authors:  Mathias Jucker
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

5.  Carboxy-terminal truncations of mouse α-synuclein alter aggregation and prion-like seeding.

Authors:  Zachary A Sorrentino; Yuxing Xia; Kimberly-Marie Gorion; Ethan Hass; Benoit I Giasson
Journal:  FEBS Lett       Date:  2020-01-24       Impact factor: 4.124

6.  Synuclein Analysis in Adult Xenopus laevis.

Authors:  Maria Carmela Bonaccorsi di Patti; Elisa Angiulli; Arianna Casini; Rosa Vaccaro; Carla Cioni; Mattia Toni
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

Review 7.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

Review 8.  α-Synuclein and nonhuman primate models of Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neurosci Methods       Date:  2015-08-03       Impact factor: 2.390

9.  Nonhuman Primate Models of Neurodegenerative Disorders.

Authors:  Marina E Emborg
Journal:  ILAR J       Date:  2017-12-01

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.